182 related articles for article (PubMed ID: 4053443)
1. Cutaneous fibrinolytic activity in scleroderma.
Lotti T; Cerinic MM; Marmugi D; Fabbri P
Clin Exp Rheumatol; 1985; 3(3):249-53. PubMed ID: 4053443
[TBL] [Abstract][Full Text] [Related]
2. Cutaneous and plasma fibrinolytic activity in systemic sclerosis. Evidence of normal plasminogen activation.
Matucci-Cerinic M; Lotti T; Lombardi A; Pignone A; Iannone F; Beneforti E; Cinotti S; Morfini M; Caignoni M
Int J Dermatol; 1990 Nov; 29(9):644-8. PubMed ID: 2125582
[TBL] [Abstract][Full Text] [Related]
3. In vivo study of scleroderma by non-invasive techniques.
Kalis B; De Rigal J; Léonard F; le Lévêque JL; De Riche O; Corre YL; Lacharriere OD
Br J Dermatol; 1990 Jun; 122(6):785-91. PubMed ID: 2369559
[TBL] [Abstract][Full Text] [Related]
4. Serum renin and renin substrate levels in scleroderma.
Fleischmajer R; Gould AB
Proc Soc Exp Biol Med; 1975 Nov; 150(2):374-9. PubMed ID: 1208551
[No Abstract] [Full Text] [Related]
5. Cutaneous and plasma fibrinolytic activities are not deficient in patients with systemic sclerosis.
Lotti T; Campanile G; Matucci-Cerinic M
J Am Acad Dermatol; 1994 May; 30(5 Pt 1):813-4. PubMed ID: 8176033
[No Abstract] [Full Text] [Related]
6. Differential expression of nitric oxide by dermal microvascular endothelial cells from patients with scleroderma.
Romero LI; Zhang DN; Cooke JP; Ho HK; Avalos E; Herrera R; Herron GS
Vasc Med; 2000; 5(3):147-58. PubMed ID: 11104297
[TBL] [Abstract][Full Text] [Related]
7. Cutaneous and subcutaneous inflammatory sclerosis syndromes.
Doyle JA; Connolly SM; Winkelmann RK
Arch Dermatol; 1982 Nov; 118(11):886-90. PubMed ID: 7138043
[TBL] [Abstract][Full Text] [Related]
8. Histological and rheological grading of cutaneous sclerosis in scleroderma.
Piérard GE
Dermatologica; 1989; 179(1):18-20. PubMed ID: 2767293
[TBL] [Abstract][Full Text] [Related]
9. The pathophysiology of the fibrosis in scleroderma skin.
Fleischmajer R; Perlish JS
Prog Clin Biol Res; 1984; 154():381-404. PubMed ID: 6382305
[No Abstract] [Full Text] [Related]
10. Frequency, levels, and significance of blood eosinophilia in systemic sclerosis, localized scleroderma, and eosinophilic fasciitis.
Falanga V; Medsger TA
J Am Acad Dermatol; 1987 Oct; 17(4):648-56. PubMed ID: 3668010
[TBL] [Abstract][Full Text] [Related]
11. [Systemic sclerosis (scleroderma) without scleroderma].
Nadashkevych ON
Lik Sprava; 2001; (3):93-4. PubMed ID: 11560041
[TBL] [Abstract][Full Text] [Related]
12. Successful treatment of scleroderma with PUVA therapy.
Kanekura T; Fukumaru S; Matsushita S; Terasaki K; Mizoguchi S; Kanzaki T
J Dermatol; 1996 Jul; 23(7):455-9. PubMed ID: 8772023
[TBL] [Abstract][Full Text] [Related]
13. Localized and systemic scleroderma.
Hawk A; English JC
Semin Cutan Med Surg; 2001 Mar; 20(1):27-37. PubMed ID: 11308134
[TBL] [Abstract][Full Text] [Related]
14. Abnormal fibrinolysis: the cause of lipodermatosclerosis or "chronic cellulitis" in patients with primary lymphedema.
Stewart G; Pattison M; Burnand KG
Lymphology; 1984 Mar; 17(1):23-7. PubMed ID: 6717074
[TBL] [Abstract][Full Text] [Related]
15. [Systemic sclerosis and scleroderma circumscripta--disturbances of selected serum parameters which are responsible for vascular changes and CD34 expression in involved skin].
Dziankowska-Bartkowiak B; Zebrowska A; Wagrowska-Danielewicz M; Kobos J; Waszczykowska E
Przegl Lek; 2009; 66(12):1040-5. PubMed ID: 20514902
[TBL] [Abstract][Full Text] [Related]
16. Localized scleroderma: clinical spectrum and therapeutic update.
Careta MF; Romiti R
An Bras Dermatol; 2015; 90(1):62-73. PubMed ID: 25672301
[TBL] [Abstract][Full Text] [Related]
17. [3H]Thymidine labeling of dermal endothelial cells in scleroderma.
Fleischmajer R; Perlish JS
J Invest Dermatol; 1977 Oct; 69(4):379-82. PubMed ID: 903666
[TBL] [Abstract][Full Text] [Related]
18. Clinical and laboratory features of systemic sclerosis complicated with localized scleroderma.
Toki S; Motegi S; Yamada K; Uchiyama A; Kanai S; Yamanaka M; Ishikawa O
J Dermatol; 2015 Mar; 42(3):283-7. PubMed ID: 25582037
[TBL] [Abstract][Full Text] [Related]
19. Localized scleroderma (morphoea). Clinical, physiological, biochemical and ultrastructural studies with particular reference to quantitation of scleroderma.
Serup J
Acta Derm Venereol Suppl (Stockh); 1986; 122():3-61. PubMed ID: 2939680
[No Abstract] [Full Text] [Related]
20. Palindromic morphea: multiple recurrence of morphea lesions in a case of systemic sclerosis.
Mizutani H; Tanaka H; Okada H; Mizutani T; Shimizu M
J Dermatol; 1992 May; 19(5):298-301. PubMed ID: 1644954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
